Reviewing Nanovibronix (FEED) and Its Competitors

Nanovibronix (NASDAQ:FEED) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare Nanovibronix to related companies based on the strength of its institutional ownership, valuation, dividends, analyst recommendations, profitability, earnings and risk.

Volatility and Risk

Nanovibronix has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Comparatively, Nanovibronix’s peers have a beta of 2.55, indicating that their average share price is 155% more volatile than the S&P 500.

Earnings & Valuation

This table compares Nanovibronix and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$1.93 million	-$18.18 million	-0.00
Nanovibronix Competitors	$1.90 billion	$137.77 million	10.86

Nanovibronix’s peers have higher revenue and earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 12.2% of Nanovibronix shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Nanovibronix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-1,093.61%	-60.73%	-48.48%
Nanovibronix Competitors	-278.38%	-150.31%	-21.96%

Analyst Ratings

This is a summary of current ratings and target prices for Nanovibronix and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	4261	10489	18226	825	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 23.63%. Given Nanovibronix’s peers stronger consensus rating and higher possible upside, analysts clearly believe Nanovibronix has less favorable growth aspects than its peers.

Summary

Nanovibronix peers beat Nanovibronix on 12 of the 13 factors compared.

Nanovibronix Company Profile

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.